This article has been updated to correct an explanation of how the test works versus the current standard of care.

NEW YORK (GenomeWeb) – Molecular diagnostics firm Transplant Genomics today announced that its TruGraf post-kidney transplant blood tests have been accepted for use by four transplant centers under an early-access program — California Pacific Medical Center, the Henry Ford Health System, Houston Methodist Hospital, and the University of Wisconsin.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.